Global Fibromyalgia Epidemiology and Patient Flow Analysis - 2016

  • ID: 3514428
  • Report
  • Region: Global
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The author announced the results of its Fibromyalgia patient population study in a new report ‘Global Fibromyalgia Epidemiology and Patient Flow Analysis - 2016’. The report provides insights into Fibromyalgia epidemiology, Fibromyalgia diagnosed patients, and Fibromyalgia treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Fibromyalgia derived from epidemiological analysis, percentage of patients diagnosed with Fibromyalgia, and percentage of patients treated with Fibromyalgia therapy.

The study helps executives estimate Fibromyalgia market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Fibromyalgia prevalence, Fibromyalgia diagnosis rate, and Fibromyalgia treatment rate for the period 2015 - 2022. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:
- Fibromyalgia: Disease Definition
- Fibromyalgia Patient Flow
- Fibromyalgia Prevalence
- Fibromyalgia Diagnosed Patients
- Fibromyalgia Treated Patients

This report will take 1-2 business days to deliver.
Note: Product cover images may vary from those shown
2 of 3
1. Fibromyalgia: Disease Definition
2. Global Fibromyalgia Patient Flow
2A. Global Fibromyalgia Prevalence
2B. Global Fibromyalgia Diagnosed Patients
2C. Global Fibromyalgia Treated Patients
3. Fibromyalgia Patient Flow in the US
3A. Fibromyalgia Prevalence in the US
3B. Fibromyalgia Diagnosed Patients in the US
3C. Fibromyalgia Treated Patients in the US
4. Fibromyalgia Patient Flow in Europe
4A. Fibromyalgia Prevalence in Europe
4B. Fibromyalgia Diagnosed Patients in Europe
4C. Fibromyalgia Treated Patients in Europe
5. Fibromyalgia Patient Flow in Germany
5A. Fibromyalgia Prevalence in Germany
5B. Fibromyalgia Diagnosed Patients in Germany
5C. Fibromyalgia Treated Patients in Germany
6. Fibromyalgia Patient Flow in France
6A. Fibromyalgia Prevalence in France
6B. Fibromyalgia Diagnosed Patients in France
6C. Fibromyalgia Treated Patients in France
7. Fibromyalgia Patient Flow in Spain
7A. Fibromyalgia Prevalence in Spain
7B. Fibromyalgia Diagnosed Patients in Spain
7C. Fibromyalgia Treated Patients in Spain
8. Fibromyalgia Patient Flow in Italy
8A. Fibromyalgia Prevalence in Italy
8B. Fibromyalgia Diagnosed Patients in Italy
8C. Fibromyalgia Treated Patients in Italy
9. Fibromyalgia Patient Flow in UK
9A. Fibromyalgia Prevalence in UK
9B. Fibromyalgia Diagnosed Patients in UK
9C. Fibromyalgia Treated Patients in UK
10. Fibromyalgia Patient Flow in Japan
10A. Fibromyalgia Prevalence in Japan
10B. Fibromyalgia Diagnosed Patients in Japan
10C. Fibromyalgia Treated Patients in Japan
11. Appendix
12. Research Methodology
12A. Sources

Table 1: Global Fibromyalgia Patient Flow (2015)
Table 2: Global Fibromyalgia Patient Flow Forecast (2015 - 2022)
Table 3: Fibromyalgia Patient Flow in the US (2015)
Table 4: Fibromyalgia Patient Flow Forecast in the US (2015 - 2022)
Table 5: Fibromyalgia Patient Flow in Europe (2015)
Table 6: Fibromyalgia Patient Flow Forecast in Europe (2015 - 2022)
Table 7: Fibromyalgia Patient Flow in Germany (2015)
Table 8: Fibromyalgia Patient Flow Forecast in Germany (2015 - 2022)
Table 9: Fibromyalgia Patient Flow in France (2015)
Table 10: Fibromyalgia Patient Flow Forecast in France (2015 - 2022)
Table 11: Fibromyalgia Patient Flow in Spain (2015)
Table 12: Fibromyalgia Patient Flow Forecast in Spain (2015 - 2022)
Table 13: Fibromyalgia Patient Flow in Italy (2015)
Table 14: Fibromyalgia Patient Flow Forecast in Italy (2015 - 2022)
Table 15: Fibromyalgia Patient Flow in UK (2015)
Table 16: Fibromyalgia Patient Flow Forecast in UK (2015 - 2022)
Table 17: Fibromyalgia Patient Flow in Japan (2015)
Table 18: Fibromyalgia Patient Flow Forecast in Japan (2015 - 2022)

Figure 1: Global Fibromyalgia Patient Flow (2015)
Figure 2: Global Fibromyalgia Patient Flow Forecast (2015 - 2022)
Figure 3: Fibromyalgia Patient Flow in the US (2015)
Figure 4: Fibromyalgia Patient Flow Forecast in the US (2015 - 2022)
Figure 5: Fibromyalgia Patient Flow in Europe (2015)
Figure 6: Fibromyalgia Patient Flow Forecast in Europe (2015 - 2022)
Figure 7: Fibromyalgia Patient Flow in Germany (2015)
Figure 8: Fibromyalgia Patient Flow Forecast in Germany (2015 - 2022)
Figure 9: Fibromyalgia Patient Flow in France (2015)
Figure 10: Fibromyalgia Patient Flow Forecast in France (2015 - 2022)
Figure 11: Fibromyalgia Patient Flow in Spain (2015)
Figure 12: Fibromyalgia Patient Flow Forecast in Spain (2015 - 2022)
Figure 13: Fibromyalgia Patient Flow in Italy (2015)
Figure 14: Fibromyalgia Patient Flow Forecast in Italy (2015 - 2022)
Figure 15: Fibromyalgia Patient Flow in UK (2015)
Figure 16: Fibromyalgia Patient Flow Forecast in UK (2015 - 2022)
Figure 17: Fibromyalgia Patient Flow in Japan (2015)
Figure 18: Fibromyalgia Patient Flow Forecast in Japan (2015 - 2022)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll